Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new revision entry (v3.4.2) to the record history. Removed the older government-funding notice and revision v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the new revision tag v3.4.1. Removed the previous revision tag v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary toggle and color-coded indicators (green for additions, red for deletions) in the study history display, with notes about revision v3.4.0 and No FEAR Act data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check42 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 in the site footer, indicating a minor maintenance update that does not affect trial data or page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 appears in the footer, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. This is a minor site maintenance update that does not affect the study record history; to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2; no study data or navigation changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.